Pearl: A Foundation Model for Placing Every Atom in the Right Location
Genesis Research Team, Alejandro Dobles, Nina Jovic, Kenneth Leidal, Pranav Murugan, David C. Williams, Drausin Wulsin, Nate Gruver, Christina X. Ji, Korrawat Pruegsanusak, Gianluca Scarpellini, Ansh Sharma, Wojciech Swiderski, Andrea N. Bootsma, Richard Strong Bowen, Charlotte Chen, Jamin Chen, Mar · 2025
Read Pearl: A Foundation Model for Placing Every Atom in the Right Location by Genesis Research Team, Alejandro Dobles, Nina Jovic, Kenneth Leidal, Pranav Murugan, David C. Williams, Drausin Wulsin, Nate Gruver, Christina X. Ji, Korrawat Pruegsanusak, Gianluca Scarpellini, Ansh Sharma, Wojciech Swiderski, Andrea N. Bootsma, Richard Strong Bowen, Charlotte Chen, Jamin Chen, Mar (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2510-24670.txt.
Introduction
Genesis Research Team and thirty nine co-authors built Pearl, a large model that places each atom of a drug and its target in three dimensions. Guessing that joint shape is a core step in drug design, yet hard lab data are scarce. Past deep models also made poses that break basic rules of shape.
Pearl trains on large sets of made up cases to fill the data gap. Its design keeps three dimensional turns in mind, so it learns shape rules more fast. At test time, users can steer its picks with extra facts. The aim is faster, more sound shape calls at scale.
Catalog record
| CREATOR | Genesis Research Team, Alejandro Dobles, Nina Jovic, Kenneth Leidal, Pranav Murugan, David C. Williams, Drausin Wulsin, Nate Gruver, Christina X. Ji, Korrawat Pruegsanusak, Gianluca Scarpellini, Ansh Sharma, Wojciech Swiderski, Andrea N. Bootsma, Richard Strong Bowen, Charlotte Chen, Jamin Chen, Mar |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2510-24670
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Pearl: A Foundation Model for Placing Every Atom in the Right Location Genesis Research Team, Alejandro Dobles, Nina Jovic, Kenneth Leidal, Pranav Murugan, David C. Williams, Drausin Wulsin, Nate Gruver, Christina X. Ji, Korrawat Pruegsanusak, Gianluca Scarpellini, Ansh Sharma, Wojciech Swiderski, Andrea N. Bootsma, Richard Strong Bowen, Charlotte Chen, Jamin Chen, Marc André Dämgen, Benjamin DiFrancesco, J. D. Fishman, Alla Ivanova, Zach Kagin, David Li-Bland, Zuli Liu, Igor Morozov, Jeffrey Ouyang-Zhang, Frank C. Pickard IV, Kushal S. Shah, Ben Shor, Gabriel Monteiro da Silva, Roy Tal, Maxx Tessmer, Carl Tilbury, Cyr Vetcher, Daniel Zeng, Maruan Al-Shedivat, Aleksandra Faust, Evan N. Feinberg, Michael V. LeVine, Matteus Pan Abstract Accurately predicting the three-dimensional structures of protein–ligand complexes remains a fundamental challenge in computational drug discovery that limits the pace and success of therapeutic design. Deep learning methods have recently shown strong potential as structural prediction tools, achieving promising accuracy across diverse biomolecular systems. However, their performance and utility are constrained by scarce experimental data, inefficient architectures, physically invalid poses, and the limited ability to exploit auxiliary information available at inference. To address these issues, we introduce Pearl ( P lacing E very A tom in the R ight L ocation), a foundation model for protein–ligand cofolding at scale. Pearl addresses these challenges with three key innovations: (1) training recipes that include large-scale synthetic data to overcome data scarcity; (2) architectures that incorporate an SO(3)-equivariant diffusion module to inherently respect 3D rotational symmetries, improving generalization and sample efficiency, and (3) controllable inference, including a generalized multi-chain templating system supporting both protein and non-polymeric components as well as dual unconditional/conditional modes. Pearl establishes a new state-of-the-art performance in protein-ligand cofolding. On the key metric of generating accurate ( RMSD ¡ 2 Å ) and physically valid poses, Pearl surpasses AlphaFold 3 and other open source baselines on the public Runs N’ Poses and PoseBusters benchmarks, delivering 14.5% and 14.2% improvements, respectively, over the next best model. In the pocket-conditional cofolding regime, Pearl delivers 3.6 × 3.6\times improvement on a proprietary set of challenging, real-world drug targets at the more rigorous RMSD ¡ 1 Å threshold. Finally, we demonstrate that model performance correlates directly with synthetic dataset size used in training. \journalname Genesis Molecular AI – Technical Report \professor Ordered alphabetically within each group \institution Genesis Molecular AI \footinfo Pearl \theday August 10, 2026 \leadauthor Genesis Molecular AI \tauabstract 1. Introduction Figure 1 : (a) Pearl prediction (magenta) superimposed on the experimental ground truth (blue) for SARS-CoV-2 (PDB: 8S8X, in the Runs N’ Poses, released March 2024); Pearl performance in the (b) unconditional (Runs N’ Poses) and (c) pocket-conditional (InternalXtals) cofolding modes; (d) Pearl training and inference flow. Small molecule therapeutics are an essential component of modern medicine, but their discovery remains a slow, expensive, and high-risk endeavor. A common approach involves building structure-activity relationship (SAR) models to predict how changes to a ligand’s chemical structure will affect its activity. While both qualitative and quantitative SAR models have been successfully used to design drugs, they require large amounts of expensive experimental data, making the process inefficient and often yielding an incomplete understanding of the activity landscape, especially activity cliffs. A key strategy to improve SAR modeling and to accelerate this process is structure-based drug design (SBDD), where scientists design new ligands by applying chemical and physical principles to 3D protein-ligand structures. Historically, SBDD has been limited by its reliance on experimentally determined structures, which are still slow and expensive to acquire. The rise of computational methods presents an opportunity to apply this approach at an unprecedented scale, using predicted 3D structures—referred to as poses —to triage candidates and to produce more information-rich SAR models. Traditionally, 3D structure prediction has been performed using physics-based ligand docking methods [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 ] . However, these methods tend to treat the protein (semi-)rigidly, and are unable to account for protein conformational changes that may occur during ligand binding [ 9 , 10 , 11 ] . On the other hand, early protein folding models treat the protein as fully flexible, but are unable to jointly predict protein-ligand complexes [ 12 ] . Recently, deep learning models have evolved beyond protein-only folding to predict more general biomolecular complexes. Pioneering systems, such as AlphaFold 3 [ 13 ] and RoseTTAFold All-Atom [ 14 ] , have demonstrated that a single model could jointly model proteins, ligands, nucleic acids, and other cofactors, predicting structures directly from their sequences and chemical topologies. The development of these models, and their descendants [ 15 , 16 , 17 , 18 , 19 , 20 ] , is a major advancement in biomolecular modeling. Crucially, these cofolding models adapt the protein binding pocket geometry to different ligands, accounting for flexibility more fundamentally than previous approaches. Despite this, achieving the reliability needed to advance drug discovery campaigns remains a significant challenge. Reliable pose prediction faces three primary challenges. First, cofolding models learn from a relatively limited and biased corpus of experimentally determined structures. The Protein Data Bank (PDB) [ 21 ] offers orders of magnitude less data than domains like text or images, and this corpus is skewed toward certain targets and chemotypes due to varying experimental difficulty and scientific interest [ 22 ] . This scarcity and bias limit generalizability, leading models to memorize common structures, rather than learn transferable rules [ 23 ] . Second, a useful binding pose must satisfy complex physical requirements, such as low ligand strain, shape complementarity, and favorable non-covalent interactions. Subtle violations can produce superficially plausible but physically incorrect ”hallucinations” that are not representative of real-world protein-ligand binding behavior. Finally, many existing models offer limited inference-time controllability, preventing them from using auxiliary structural information, such as a homologous ligand-bound structure, which are often available in real-world discovery programs. To overcome these challenges, we introduce Pearl ( P lacing E very A tom in the R ight L ocation), a generative foundation model for biomolecular structure prediction (Figure 1 ). Pearl addresses data scarcity and bias by training on a diverse mixture of experimental and synthetically generated protein-ligand complexes. Its novel architecture and training protocol (Figure 1 ) are designed to better learn the physical principles of binding, improving both generalization and the physical validity of generated poses. Furthermore, Pearl is explicitly built for adaptability and use during drug discovery campaigns. Its novel multi-chain templating system acts as a flexible conditioning mechanism, allowing scientists to leverage auxiliary structural information about the target protein, cofactors, and related ligands. This paper makes three key contributions. First, we provide evidence for model performance scaling by training with large-scale synthetic data. Second, we introduce key modeling innovations, including curriculum training and an architecture that encompasses an SO(3)-equivariant diffusion module. Third, we develop a novel multi-chain templating system that incorporates non-polymeric information. This provides two key benefits: it enables conditioning on structural information during inference, and it supplies contextual data during training. Taken together, these contributions establish Pearl as the new state-of-the-art model for protein-ligand cofolding. Pearl achieves 85.2% and 84.7% success rates for generating accurate and physically valid poses on Runs N’ Poses and PoseBusters benchmarks, respectively—both significant ( \mathrm{p}\leq 0.001